Equities

ImmuPharma PLC

IMM:LSE

ImmuPharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2.35
  • Today's Change0.11 / 4.91%
  • Shares traded1.32m
  • 1 Year change-23.08%
  • Beta2.3953
Data delayed at least 20 minutes, as of Apr 19 2024 16:05 BST.
More ▼

Key statistics

On Friday, ImmuPharma PLC (IMM:LSE) closed at 2.35, -38.16% below its 52-week high of 3.80, set on Jun 19, 2023.
52-week range
Today
0.822Mar 04 20243.80Jun 19 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open2.20
High2.30
Low2.20
Bid2.26
Offer2.40
Previous close2.24
Average volume1.26m
Shares outstanding416.44m
Free float237.37m
P/E (TTM)--
Market cap9.33m GBP
EPS (TTM)-0.0092 GBP
Data delayed at least 20 minutes, as of Apr 19 2024 16:05 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.